You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • LB0002 A FIRST IN CLASS THERAPEUTIC NANOPARTICLE FOR SPECIFIC TARGETING OF ANTI-CITRULLINATED PROTEIN ANTIBODY AMELIORATES SERUM TRANSFER AND COLLAGEN INDUCED ARTHRITIS

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Late breaking abstracts
New technologies in translational rheumatology
LB0002 A FIRST IN CLASS THERAPEUTIC NANOPARTICLE FOR SPECIFIC TARGETING OF ANTI-CITRULLINATED PROTEIN ANTIBODY AMELIORATES SERUM TRANSFER AND COLLAGEN INDUCED ARTHRITIS

 

Online download statistics by month:

Online download statistics by month: June 2020 to April 2023

AbstractFullPdf
Jun 20201803
Jul 20202000
Aug 20201401
Sep 202056012
Oct 20201401
Nov 20202202
Dec 20201303
Jan 20214901
Feb 20213603
Mar 20212100
Apr 20211801
May 20211001
Jun 2021002
Aug 2021802
Oct 20211800
Nov 20213003
Dec 20212500
Jan 20221801
Feb 2022600
Mar 20222101
Apr 20222601
May 20224902
Jun 20221901
Jul 20222300
Aug 20222701
Sep 20221001
Oct 20221500
Nov 20222900
Dec 20224400
Jan 20232001
Feb 20231302
Mar 20231402
Apr 20233000
Total736048